Anixa Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.96

+0.21 (+7.64%)

As of Feb 8, 2:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +412.8% upside

Low Target $12.50

Average Target $15.18

High Target $18.81

Current Price $2.96

Current
$2.96

Target
$15.18

$12.50 $15.18 avg $18.81

Scenario Analysis

Bear Case

$12.50

322.3%

Low target

Base Case

$15.18

+412.8%

Avg target

Bull Case

$18.81

+535.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$16.43

-82.0% from high

52-Week Low

$7.49

+-60.5% from low

Target vs 52W High

$15.18

-7.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%